CTLA4-Ig gene therapy
Alternative Names: AdCTLA4IgLatest Information Update: 20 Jul 2006
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart transplant rejection; Lung transplant rejection; Rheumatoid arthritis